All Industries

BGX-Black Gold Exploration CEO Francisco Gulisano on company projects and prospects

BGX Black Gold Exploration

BGX Black Gold Exploration Ord Shs (CSE:BGX) CEO Francisco Gulisano provides an overview of the company in an interview with Proactive's Stephen Gunnion. Black Gold Exploration is involved in the exploration of natural resources, primarily in Argentina and other American countries. Currently, it is focused on the El Carmen hydrocarbon project along the northern margin of the San Jorge Cretaceous age sedimentary basin, where it aims to certify resources. Gulisano highlighted the company's plans for seismic and drilling operations, mentioning its efforts to manage environmental impact. Additionally, the company is pursuing new projects in Argentina, where the government is supportive of foreign investment and offers tax benefits for exploration activities. The new president's pro-investment stance is seen as a positive development for the company. Gulisano mentioned the environmental and engineering agreements in place with the government to facilitate their operations. Regarding the El Carmen basin, Gulisano noted the presence of natural gas and the potential for oil resources, emphasizing ongoing exploration efforts. He mentioned the commencement of environmental jobs and surveys in the area and promised updates on their progress. Contact Details Proactive North America Proactive North America +1 604-688-8158 NA-editorial@proactiveinvestors.com

June 10, 2024 09:00 AM Eastern Daylight Time

Video

AI's Promise On Display: BEN Collaborates With SAIL, Of Weill Cornell Medical Center, To Explore AI For Training Doctors, Improving Patient Outcomes

Benzinga

By Meg Flippin, Benzinga AI is taking off and that’s not lost on Brand Engagement Network Inc. (NASDAQ: BNAI) investors. The maker of AI assistants and avatars just closed a private placement, raising $4.95 million from a group of existing investors. That gives BEN the firepower to continue to develop its AI assistants in-house and through buys. With its human-like AI assistants, BEN is improving businesses’ customer service, productivity and performance, going after markets with a massive workforce gap and an opportunity to transform how consumers engage with networks, providers and brands. The company’s secret sauce is a broad portfolio of conversational AI applications that drive better customer experience, increased automation and operational efficiencies. Take its virtual adherence assistant for the healthcare industry as one example. BEN says its conversational AI can improve patient experiences and medication understanding, leading to better outcomes. Or its “Remember Me” technology which syncs digital and physical interactions for an integrated, personalized customer experience. Investor Show Of Confidence Those advances and many others the company has made since launching its U.S. business in 2018 underpin the why of the recent deal with its existing investors. “The private placement represents a powerful vote of confidence in our strategy from our board, executive team and our existing investors,” said Chairman Chris Gaertner. “This investment will allow BEN to continue to fund its business plan as it seeks to execute on its growth and revenue strategies.” The investment comes as the AI market is taking off, as new use cases validate this transformational technology. The AI market is forecast to soar to $1.3 trillion in the years to come, growing at a CAGR of 42% over the next decade. Rising demand for generative AI products could add about $280 billion of new software revenue, driven by specialized assistants, new infrastructure products and copilots that accelerate coding. Not only did the investors double down on BEN, but they were willing to do so at a premium, purchasing warrants and stock at $2.50 a share – materially above where shares were trading at the time. Some of the investors agreed to provide BEN with additional capital through the exercise of their warrants if the company is unable to raise an additional $3.25 million by October 31, bringing the total investment to $8.25 million. That gives BEN a lot of capital to use to strike up partnerships and make buys. Deep Management Bench It's an area that Michael Zacharski, now co-CEO of BEN after the promotion of Paul Chang to the newly created role of co-CEO, will head up. Zacharski has more than 15 years of experience in the tech industry, making a name for himself for his ability to drive growth, optimize operations and spearhead M&A. “This is a pivotal time for the AI industry, and we’re excited about the prospect of partnering with organizations that complement our vision and capabilities,” said Zacharski. “I am excited to focus on furthering the company’s M&A strategy, which we believe will be core to our business strategy moving forward.” Chang, who has been global president since May 2023, will oversee commercial operations as co-CEO, focusing on validating the market and growing the business commercially. Chang spent 18 years at IBM (NYSE: IBM) creating new markets for emerging technologies as well as several start-ups. “I am thrilled to take on the role of co-CEO,” said Chang. “As we transition into delivering value to our customers by commercializing our safe and comprehensive Gen AI Platform, BEN is well positioned both financially and technologically to execute our plans. With our unique design and architecture as well as portfolio of patents, we hope to demonstrate to the market that our AI Assistants are ready to contribute to businesses in areas that can increase CX, help to complete tasks and fuel their growth.” Rounding out the C-Suite at BEN is Chief Financial Officer Bill Willams. Williams brings over twenty years of experience in corporate finance, legal, technology and management consulting to BEN. He is an expert in driving growth, innovation and value creation for emerging growth companies. AI is taking off, and BEN wants to be a leader in helping businesses streamline operations and enhance customer service with this transformational technology. With fresh cash in its coffers and the backing of a supportive board and investors, BEN seems like an AI story to follow. Featured photo by Steve Johnson on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

June 10, 2024 08:45 AM Eastern Daylight Time

Image

Elicio Therapeutics Unveils Promising Phase 1a Data For ELI-002 7P In mKRAS Tumors

Benzinga

By Kyle Anthony, Benzinga Elicio Therapeutics (NASDAQ: ELTX) has announced that preliminary data from their AMPLIFY-7P Phase 1a Study of ELI-002 7P in patients with mKRAS-driven solid tumors was well tolerated with T cell responses correlating with a reduction in tumor biomarkers at the recommended Phase 2 dose (“RP2D”). Elicio Therapeutics is a clinical-stage biotechnology company focused on developing innovative lymph node-targeted immunotherapies to treat aggressive cancers. Given the firm’s expertise in materials science, immunology and oncology, it plans to forge a new path forward for cancer treatment by utilizing its diverse capabilities to fulfill its mission of amplifying the potential of immunotherapies, empowering patients to fight cancer with full force. The initial findings from its study are encouraging, given that KRAS mutated cancers are difficult to target in part due to the number of diverse mutations and bypass resistance mechanisms. “We are encouraged by the first data from the ongoing AMPLIFY-7P trial, which demonstrate ELI-002 7P has a favorable safety profile and early antitumor effects that correlate with induction of T cells specific for multiple KRAS mutations potentially providing broader coverage for patients, said Craig E. Devoe, M.D., MHCM., chief of the Division of Medical Oncology & Hematology and the R.J. Zuckerberg Cancer Center, and scientific investigator at Northwell Health. Elicio Therapeutics Pipeline Elicio Therapeutics’ lead product candidate, ELI-002, is a structurally novel investigational Amphiphile (AMP) cancer vaccine that targets cancers that are driven by mutations in the mKRAS-gene — a prevalent driver of many human cancers. ELI-002 is comprised of two powerful components that are built with Elicio Therapeutics’ AMP technology, consisting of AMP-modified mutant KRAS peptide antigens and an AMP-modified CpG adjuvant that is available as an off-the-shelf subcutaneous administration. ELI-002 2P (2 peptide formulation) is currently being studied in an ongoing Phase 1 (AMPLIFY-201) trial in patients with high relapse risk mKRAS-driven solid tumors following surgery and chemotherapy. ELI-002 7P (7 peptide formulation) is being studied in a Phase 1/2 (AMPLIFY-7P) trial in patients with mKRAS-driven pancreatic cancer. The ELI-002 7P formulation is designed to provide immune response coverage against seven of the most common KRAS mutations(G12D, G12R, G12V, G12A, G12C, G12S and G13D) present in 25% of all solid tumors, thereby increasing the potential patient population for ELI-002. Compelling Results From The Ongoing AMPLIFY-7P Phase 1a Study The company reports that the efficacy of ELI-002 7P as a treatment solution was successful in several instances, demonstrating the versatility of the drug and its ability to provide a strong T cell response. The preliminary data findings from the ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P include: ELI-002 7P administered as a monotherapy was well tolerated and able to generate a ~100x mKRAS-specific expanded T cell response relative to baseline levels ELI-002 7P generated an mKRAS-specific T cell response in 100% of patients including responses targeting all mKRAS mutations enrolled (G12D, V, R and G13D) mKRAS-specific T cells were polyfunctional with 66.7% (4/6) of evaluable patients having both CD8+ and CD4+ responses at the 4.9 mg Phase 2 dose level Tumor biomarker reductions were observed in 5/7 (71%) of evaluable patients at the 4.9 mg Phase 2 dose level ELI-002 7P was shown to induce antigen-spreading with increased T cell responses targeting non-immunizing, personalized tumor neoantigens in 6/6 (100%) of evaluable patients at the 4.9 mg Phase 2 dose level In speaking about these findings, Christopher Haqq, MD, PhD, executive vice president, head of Research and Development and chief medical officer at Elicio Therapeutics, stated, “These early immunogenicity and biomarker response data from ELI-002 7P continue to provide encouraging results showing that our lymph node-targeted approach generates a robust and differentiated T cell response that strongly correlates with tumor biomarker reductions.” “Across two trials, ELI-002 has demonstrated an ability to generate a robust T cell response against all mKRAS mutations of enrolled patients as well as T cell responses against non-immunizing personalized tumor neoantigens. ELI-002’s broader KRAS mutation coverage and higher T cell responses with the 7-peptide vaccine at the Phase 2 dose holds promise for the high unmet need of patients with KRAS-mutated tumors,” Haqq said. The AMPLIFY-7P Phase 1a Study data findings of ELI-002 7P were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, held from May 31 to June 4, 2024, in Chicago, IL. The ASCO Annual Meeting is considered the premier international forum for presenting scientific research and state-of-the-art education in clinical oncology. The five-day event attracts 30,000 attendees from around the world. An Immunotherapeutics Company Founded as a spin-out from the Massachusetts Institute of Technology (MIT), Elicio Therapeutics leverages the research of Professor Darrell Irvine, a Howard Hughes Investigator and expert in biomedical engineering and immunology. The company's main innovation, the Amphiphile (AMP) platform, delivers immunotherapeutics directly to the body’s lymph nodes to enhance the immune system's cancer-fighting mechanisms. By delivering cancer immunotherapies to the center of the immune response, Elicio Therapeutics intends to optimize the natural ability of the lymph nodes to educate, activate, and amplify cancer-specific T cells. Elicio Therapeutics' mission is to give patients battling cancer the best possible outcome. The firm’s leadership and scientific advisory board are composed of determined and experienced individuals who are committed to engineering lymph node–targeted immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. The Path Forward Elicio Therapeutics’ recent findings are encouraging news and a tailwind for the firm’s innovation activities. Given the applicability of ELI-002 7P in treating patients with differing cancers, this is a milestone moment for Elicio Therapeutics and an encouraging step forward in the firm’s research and development and eventual commercialization of its treatment offering. As such, the benefit that Elicio Therapeutics provides and the value proposition the firm espouses could continue to grow and have increased industry resonance. Featured photo by CDC on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

June 10, 2024 08:30 AM Eastern Daylight Time

Image

Battery Mineral Resources Corp. Announces Closing of the Second Drawdown of Credit Facility with Fiera Enhanced Private Debt Fund

Battery Mineral Resources Corp.

Battery Mineral Resources Corp. ( TSXV: BMR ) ( OTCQB: BTRMF ) (“ Battery ” or “ BMR ” or the “ Company ”) is pleased to announce that its wholly-owned subsidiary, ESI Energy Services Inc. (“ESI”), has completed its second and final drawdown of C$3,000,000 under a Credit Agreement (the “Credit Agreement”) with Fiera Enhanced Private Debt Fund (“Fiera”). The terms of the Credit Agreement were disclosed in the Company press release dated, March 11th, 2024. Max Satel, Battery’s CFO stated, “We are pleased to have closed the second and final drawdown of the financing with Fiera. Battery Minerals is continuing to ramp up copper concentrate production and to further enhance operations at our Punitaqui Mining Complex, which will advance us towards our mission of building a mid-tier copper producer." About Battery Mineral Resources Corp. Battery Mineral Resources’ mission is to build a mid-tier copper producer and it has recently initiated mine and mill operations at the Punitaqui Mining Complex, a historic copper-gold-silver producer, in the Coquimbo region of Chile. Battery Mineral Resources is unique because it leverages the inherent value from its 100% owned subsidiary, ESI Energy Services Inc., a renewable energy equipment rental and sales company. Battery Mineral Resources’ portfolio also consists of two cobalt assets and one graphite asset located in North America, South America and South Korea. The Company is focused on providing shareholders accretive exposure to copper and the global mega-trend of electrification while being focused on growth through cash-flow, exploration, and acquisitions in favorable mining jurisdictions. Neither the TSX Venture Exchange (the “TSXV”) nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this press release Forward Looking Statements This news release includes certain “forward-looking statements” under applicable securities laws. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements reflect the beliefs, opinions and projections of the Company on the date the statements are made and are based upon a number of assumptions and estimates that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies. Many factors, both known and unknown, could cause actual results, performance, or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements and the parties have made assumptions and estimates based on or related to many of these factors. Such factors include, without limitation, the intended use of the proceeds of the draws under the Credit Agreement, risks related to share price and market conditions, the inherent risks involved in the mining, exploration and development of mineral properties, the ability of the Company to meet its anticipated development schedule, government regulation and fluctuating metal prices. Accordingly, readers should not place undue reliance on forward-looking statements. Battery undertakes no obligation to update publicly or otherwise revise any forward-looking statements contained herein, whether as a result of new information or future events or otherwise, except as may be required by law. For further information regarding the risks please refer to the risk factors discussed in Battery’s most recent Management Discussion and Analysis filed on SEDAR+. Contact Details Battery Mineral Resources Corp. Martin Kostuik, CEO +1 604-229-3830 info@bmrcorp.com Company Website https://bmrcorp.com/

June 10, 2024 05:30 AM Pacific Daylight Time

In A Show Of Confidence For OneMeta's AI Technology, Microsoft Adds Verbum For Teams To Its App Stores

Benzinga

By Meg Flippin, Benzinga OneMeta Inc. (OTCQB: ONEI), the AI-powered translation and transcription services company, is making strides in removing language barriers for businesses and consumers. The company recently announced its Verbum for Microsoft Teams was added to all of Microsoft Corp.’s (NASDAQ: MSFT) app stores, including Teams Store, Microsoft AppSource and directly via the Azure Marketplace. That’s a big deal for Bountiful, Utah-based OneMeta, which is busy churning out advanced technology that translates and transcribes spoken and written words in seconds across multiple languages. Being added to the Microsoft app stores validates OneMeta’s technology and gives it access to a larger potential customer base. After all, over one million businesses use Teams, including 91% of Fortune 100 companies. “Since OneMeta achieved Microsoft co-sell-ready status, we have seen significant interest from customers who want to apply the Verbum software to their usage of Microsoft Teams in the 140+ languages we offer,” said Saul Leal, CEO of OneMeta. “The certification by Microsoft brings confidence to our clients and to the great work that OneMeta is pioneering in the space. We can bring our AI for translation and transcription to all enterprises without compromising privacy, compliance, and data security.” Crashing Language Barriers Thanks to the internet, businesses big and small are increasingly global. Whether customers are based around the globe or employees are living in far-flung corners of the world, being able to communicate regardless of their language is key to growing and thriving. It's why the AI translation and transcription industry is growing. In 2023, the global natural language processing market was valued at $24.10 billion. By 2032, it is expected to reach $158.04 billion, growing at a CAGR of 23.2% during the forecast period. OneMeta wants to be a leading player in the space, translating in near real-time whether users are attending a live event, participating in an online meeting, or talking on the phone. Thanks to its proprietary NLP technology, the company specializes in breaking down linguistic barriers in a multilingual world. It ensures fast and accurate translations and transcriptions. OneMeta recently reduced the translation and transcription speed of over 150 languages and dialects to less than 200 milliseconds. Augmenting Microsoft Teams While Microsoft Teams provides live captioning capabilities in various languages, OneMeta said Verbum enhances that by delivering simultaneous interpretation across over 140 languages by harnessing state-of-the-art AI. With Verbum for Teams, multilingual groups can truly come together in meetings. Each attendee chooses the language they are speaking in and the language they want to see captions and chat in. As each person speaks in their preferred language from a list of 95+ languages, it is translated in near real-time for the rest of the group. OneMeta says Verbum for Teams is meticulously designed for seamless integration with Microsoft Teams to ensure all participants in video conferences and collaborative engagements can interact smoothly, transcending language barriers. That can empower organizations to cultivate more inclusive and engaging interactions, augmenting the inherent functionalities of Microsoft Teams and expanding the scope of communication possibilities while maintaining an optimal user experience, said OneMeta. "Now that Verbum for Teams is available on the Teams store, AppSource Marketplace, the Azure Marketplace, and the Microsoft Certification has been published, we expect to see Verbum's adoption and growth by organizations that need multi-language translation and transcription,” Alessandro Balzarelli, Director at Microsoft Industry Solutions Engineering, said. “Verbum empowers Microsoft Teams users to be more efficient and more inclusive within their own organizations and with their own customers." Communications are the backbone of businesses, whether they are local or operating internationally. OneMeta recognizes that and is developing products to help people do that regardless of their language or platform. Verbum for Teams is a perfect example of that effort. Being part of the Microsoft family goes a long way in showcasing OneMeta’s AI prowess. Featured photo by Dimitri Karastelev on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

June 10, 2024 08:25 AM Eastern Daylight Time

Image

Italian Founders Fund raises inaugural €50m for seed and pre-seed startups

Italian Founders Fund

Italian Founders Fund (IFF), the first-ever Italian Venture Capital fund created by founders, for founders is today announcing the launch of its debut €50m fund. Backed by a diverse group of Italian entrepreneurs covering a range of generations and sectors, IFF is driven by a shared goal: empowering Italy’s next generation of exceptional talent and digital innovation. With over €50 million of entirely private capital raised, the fund was born as a direct response to the Italian founders community's desire to put Italy on the map of the best spots in Europe to open a company. Italian Founders Fund’s investment strategy focuses on being the lead investor in the pre-seed and seed rounds of innovative startups led by Italian founders, whether operating in Italy or abroad, while also being able to target foreign startups interested in entering the Italian market. IFF is led by Lorenzo Franzi, former partner at Global Founders Capital. Lorenzo brings a remarkable international professional background, ranging from investment banking to experience as the founder of a digital startup. After many years abroad, Lorenzo has returned to Italy to launch the fund by partnering with a group of the best Italian founders. Lorenzo Franzi, founding partner at Italian Founders Fund commented: “A new chapter has begun for the Italian Venture Capital ecosystem. We’ve brought over 100 founders onboard, including key figures from Italy’s entrepreneurial and innovation sector, and we also have representatives from the firmly established business owner/investor community. This positions us to set up a truly integrated system that can promote and support Italy’s promising ecosystem both at home and on the global map. We are convinced that by unifying the country's ambitions and talents, we’ll help shape our future economy for the better. “Thanks to the background and network of our founder-investors, we aim to enable promising projects to emerge and grow, transforming untapped potential into companies capable of generating value, change, and jobs. I believe this is a significant sign of maturity for the Italian digital ecosystem, as seen in other countries where the presence of VC funds fueled by private capital and the experience of successful founders is a clear indication of a maturing and growing ecosystem.” The fund, housed within the management company Koinos Capital SGR, stands out on the peninsula for its uniquely collaborative community approach. In addition to funding, IFF offers its portfolio companies the expertise, experience, time, and network of a diverse and highly qualified investor base. Within the IFF, founder investors also actively participate in the process of identifying investment opportunities and analyzing them, allowing the investment team to gain an even deeper understanding of the sector and the challenges faced by target companies. By becoming the top investment network for ambitious Italian founders, IFF will serve as a privileged gateway for international funds looking to invest in Italy, facilitating co-investment from the earliest stages. IFF aims to complete 25 transactions over its investment period, with initial investments ranging from €500,000 to €1.5 million and the possibility of accessing an additional €2.5 million in subsequent rounds. From the very beginning of its fundraising stage, the initiative has registered remarkable interest, allowing the fund to quickly finalize its first two investments. The first announced investment is in Jet HR, a tech company focused on removing the pain of HR management bureaucracy. This investment marked the largest pre-seed round in Italy, with IFF co-investing alongside Exor Ventures. And it’s paying off: in just a few months since its official launch, JetHR has already achieved €1 million in annual recurring revenue, positioning itself among the top 10% of Software as a Service startups in the world when comparing rapid growth. IFF’s second investment has been made in Glaut, aiming to improve the market research and surveys sector using artificial intelligence. Glaut's round involved the participation of various international funds and angels. Beyond these completed deals, three new transactions are currently in the finalization stage. Marco Ogliengo, founder and CEO at Jet HR added: “So many VCs claim there's more value than just the money but, too often, founders are left shortchanged on value. IFF is unique, however, as it's backed by basically every successful Italian founder, and the partners are founders themselves. It's a very powerful network, giving you better access than any other VC in Italy can today." Marco Morgese, CEO of the management company KOINOS Capital SGR commented: "This type of founder-led fund is already prevalent in markets where innovation is at the forefront of industrial development policies. We see them in the USA with Founders Fund, which has been around for almost 20 years, as well as in Europe where 10x founders operates in Germany, Galion.exe in France, ByFounders in Scandinavia, and Dutch Founders Fund in the Netherlands. Given the crucial role of innovation in the country's industrial development, the IFF project represents the natural evolution of Koinos. We have been transitioningfrom a private equity fund supporting small and medium-sized Italian businesses to a multi-asset platform encompassing both private equity and venture capital, all while maintaining a strong entrepreneurial spirit.” About Italian Founders Fund Italian Founders Fund (IFF) is the first-ever Italian Venture Capital fund created by founders, for founders. Backed by a diverse group of Italian entrepreneurs covering a range of generations and sectors, the fund was born in direct response to the Italian founders community's desire to put Italy on the map of the best spots in Europe to open a company. IFF is driven by a shared goal: to invest in and empower Italy’s next generation of exceptional talent and digital innovation. For more information please visit https://italianfoundersfund.com/ or follow via LinkedIn. Contact Details Italian Founders Fund Bilal Mahmood +44 7714 007257 b.mahmood@stockwoodstrategy.com Company Website https://italianfoundersfund.com/

June 10, 2024 08:00 AM Eastern Daylight Time

Image

Room to Roam: ‎The Elephant’s Path to Climate Resilience

News Media Group, Inc.

Contact Details Karl Wayne +1 334-440-6397 karl@newsmg.com Company Website https://newsmg.com/

June 10, 2024 07:00 AM Eastern Daylight Time

Video

Dogwifhat Hype Cools Down: Holders Jump Ship To Floki And Viral AI Meme Coin Raboo!

Total Media

Following the surge of meme coins into the digital space, crypto holders have now seen an opportunity to make an investment and get great returns. Because the value of these coins is rising quickly, it is hard not to see a crypto enthusiast who has yet to invest in at least one. These coins are an excellent market opportunity and many of them have proven to be of great value to investors who hold them. Two exciting meme coins held by many investors today include Dogwifhat and Floki. These coins, just like many other meme coins, have been invested in before their launch date and have turned out to be valuable. But with a new meme coin, Raboo, coming into the market space, you could even get a much greater return. The returns are so promising that the value of the coin can rise 233% in its presale token on launch day. Watch out for Raboo! Dogwifhat Holders Are Looking For Alternatives Dogwifhat is a popular meme coin held by many investors and there has been an uptrend in its value judging from when it started. However, the trend in the value of Dogwifhat recently hasn't favored those who hold this coin, especially recent buyers. The value of a Dogwifhat is $3.43 and in the last 24 hours, there has been a 2.3% drop in value. The recent bearish movement of the coin has made the coin holders fear that they might lose a lot and has caused them to look for better options that will give them a better return on their investment. Floki Rises 30% in Value Following the latest uptrend, Floki has hit the highest value it has ever been since its launch. This rise has exposed the Floki to the general public and has made it one of the best coins to buy now in 2024. The value rise of Floki has caused crypto enthusiasts to invest their money into it. However in the last 24 hours, there has been a 4.6% drop in value and the coin now trades at $0.00031 per token. Recent buyers hope the recent drop in value is just a glitch and expect that the uptrend will continue. They also won't pass on the opportunity to invest in other meme coins that show a promising future. Raboo Storms The Market Raboo is a top digital coin built by the best developers. It is a new AI meme coin expected to burst into the crypto market soon. Experts say Raboo is one of the best coins to buy now especially if you are a newbie in the crypto world or a veteran hoping to make the most of meme coins. The exciting thing about Raboo is that you don't have to wait till its launch day before you make returns. Raboo holders can grab exciting $RABT tokens and win exclusive rewards when it is launched into the market. Raboo has been looked into by many analysts and they have given nothing but positive reviews. They predict that Raboo will overtake many meme coins including Dogwifhat and Floki before the end of 2024 and in years to come, it will be one of the leading coins in the market. At the moment, Raboo’s presale token goes for $0.0048 and it's in the fourth Stage of presale. There are already over 8,000 registered users and you can be a part of this great community. Be a part of this community and earn while you interact. Conclusion Investors of Dogwifhat and Floki now see Raboo as a better option to invest in. Aside from earning, Raboo comes with extra benefits that you shouldn't miss out on. You can participate in the Raboo presale here: Telegram: https://t.me/RabootokenPortal Twitter: https://twitter.com/Raboo_Official Contact Details Total Media Solutions media@Totalsolutionspr.io

June 09, 2024 12:00 PM Eastern Daylight Time

Image

Ripple Selling 400m XRP, Price Dump Incoming? JASMY Fluctuates As Investors Shift To New Viral Contender

Total Media

The longstanding Ripple (XRP) lawsuit is affecting XRP's trading price, and its investors are getting agitated. Apparently, Ripple could be facing a long year in the crypto market with all the token dumps this year. The other option is not so great either, as JasmyCoin's recent pumps and dips have left the long-term users in doubt. Here's a bit on the upcoming meme giant. Ripple is facing even grimmer times ahead in the crypto market If you thought XRP was in bearish waters, the next few weeks are about to get rougher. And it has a lot to do with the ongoing legal battles with the Securities and Exchange Commission. Already, Ripple's place among the top altcoins is threatened. About two weeks ago, some whale accounts dumped their tokens on BitStamp and Bitso, amounting to about $50 Million worth of XRP. While many thought that it might just be Ripple unlocking more tokens, there's been a more recent three-billion-dollar offload from the Escrow account to Ripple's wallet. The huge Ripple price movements have been suspect among Ripple whales, and there could be sell pressure on the XRP token following such activities. So far, Ripple hasn't offered any explanation for the huge movements, and XRP is still on a 0.33% loss after a largely unremarkable month. JasmyCoin (JASMY) might not be the alternative investors expect JasmyCoin hit the crypto news with its pump two weeks ago, which has helped JASMY to 99% monthly gains. May was a great month for JASMY, but the token fell due to token dumping early in June. DWF Labs deposited about 97 million JASMY tokens ($3.3 million) on Binance over the past three days, resulting in a dip in JasmyCoin's timeframes at every deposit. The cascade didn't end there, as many more JasmyCoin traders have also decided to cash in on the token. The profit-taking has eaten into the JASMY price pump throughout May, and the token is now down to 2.24% on the daily chart. The effects of large token holders could affect traders, and many investors are already off to the next big thing in the crypto market. Thankfully, it's not too far away; Raboo's presale is here! Raboo is a more consistent bullish option for summer traders Raboo opened the summer with $0.003 on its presale, and everyone expects a spike of 233% from the event. The $RABT token has pumped to 60% profits, as each token now goes for $0.0048. The meme project will leverage AI to create memes fit for entertainment. Unlike its meme counterparts, Raboo plans to keep the meme stream fresh every day. With even funnier memes, $RABT is set to become the next best thing in the crypto-verse. The traffic that will hit the platform could bring a pump to outpace Dogecoin's surge in 2021. However, profits are not all Raboo has its sights on. The members of the $RABT community are the first beneficiaries of the ecosystem. They have a chance to monetize their social media posts through Raboo, as the generative AI is on hand to convert all that content into profits. Conclusion The fun part about Raboo is that you can start earning even more $RABT tokens as soon as you get some of yours from the presale. The project is in Stage 4 of presales and going for $0.0048. Stage 1 investors are already pocketed 60% ROI, and Raboo could turn in 100x gains once it lists. With its AI use cases, your Raboo investments are set for life. You can participate in the Raboo presale here: Telegram: https://t.me/RabootokenPortal Twitter: https://twitter.com/Raboo_Official Contact Details Total Media Solutions media@Totalsolutionspr.io

June 08, 2024 05:55 PM Eastern Daylight Time

Image

1 ... 184 185 186 187 188 ... 3787

Back